India Mandates Lower Cancer Drug Prices After Court Ruling

India's government has ordered a significant reduction in the prices of essential cancer medications following a high court ruling that deemed excessive mark-ups by pharmaceutical companies as "extortionate."

The decision aims to make life-saving treatments more accessible and affordable for patients across the country, addressing concerns about the financial burden of cancer care. This move is expected to impact the pricing strategies of pharmaceutical manufacturers operating within India.